Abstract: A pharmaceutical composition for treating peripheral circulation disorders, which is an emulsion containing an isocarbacyclin having the following formula (1): ##STR1## wherein R.sup.1 is a hydrogen atom or alkyl group and R.sup.2 is a alkyl group which may be substituted with, a alkenyl group or alkynyl group which may be substituted with, or a cycloalkyl group which may be substituted with, in an amount of 0.2 to 1,000 .mu.g per ml of the composition, a vegetable oil in an amount of 0.05 to 0.5 g per ml of the composition, a phospholipid in an amount of 0.01 to 0.5 g per g of the vegetable oil, and water is provided.

Abstract: A digital magnetic recording/reproducing apparatus comprising a unit for recording high-definition information including video information and audio information, which is based on a first high-definition television scheme, on a recording medium in accordance with a second high-definition television scheme, the first high-definition television scheme having a first data format of a first amount of information smaller than a second amount of information of a second data format of the second high-definition television scheme, the recording unit including a circuit for allocating a recording area corresponding to a difference between the first amount of information and the second amount of information as a free recording area on which any information is selectively recorded, to match the first amount of information with the second amount of information.

Abstract: A kit for the immunological assay of the human tissue plasminogen activator-human plasminogen activator inhibitor complex in a human specimen, which kit comprises(i) a monoclonal antibody (first antibody) against a human plasminogen activator inhibitor linked onto an insoluble solid carrier having a specular surface,(ii) a polyclonal antibody (second antibody) against a human tissue plasminogen activator labelled by an enzyme,(iii) a substrate and a reaction-discontinuing agent for the assay of the enzyme activity,(iv) a diluent, and(v) a detergent containing a nonionic surfactant having an HLB (Hydrophile Lipophile Balance) value of at least 16,and a method for the immunological assay of the above complex and a method for the immunological assay of the active human plasminogen activator inhibitor, respectively in a human specimen using this kit.